Paramount BioCapital
Paramount BioCapital, Inc., an affiliate of Paramount Capital group of companies, is a broker-dealer registered by the Financial Industry Regulatory Authority (FINRA) and investment firm in the United States that specializes in conducting private financings for public and private development stage biotechnology companies and promising in-licensed [...] candidates.
Background/history
In 1991 Lindsay A. Rosenwald, M.D., established Paramount BioCapital that, among other activities, has since been raising capital for the Paramount Capital Portfolio Companies. More than 40 starts up companies, including Cougar Biotechnology, Bionovo Inc., Ziopharm Oncology, Innovive Pharmaceuticals,Novadel Pharma, Tikvah Therapeutics, Inc., VioQuest Pharmaceuticals, and many others have been created over the past 19 years.
Since its inception, Paramount BioCapital and its affiliate companies have been involved in the clinical development of more than 50 [...] candidates, some of which have reached the market (including leukemia [...], Arsenic Trioxide, which progressed from Investigational New [...] to New [...] Application in AbOUT 30 months â the fastest regulatory approval in U.S. Food and [...] Administration (FDA) history; Sulodexide (KRX-101) for diabetic nephropathy licensed into Keryx Biopharmaceuticals, Inc.; milnacipran for fibromyalgia syndrome licensed from Pierre Fabre Medicament; CH-1504 (MobileTrex) for rheumatoid arthritis licensed from University of South Alabama College of Medicine by Chelsea Therapeutics. Over 30 compounds still undergo clinical development today.
Biotechnology development
Paramount BioCapital, Inc. has an extensive experience in all facets of the emerging life sciences companies development. It provides its portfolio companies a wide range of consulting and financial support services and dedicates its own capital to support companies through formation, in-licensing of potential [...] candidates and the initial stages of product development. Additional funds are raised from institutional and private investors by taking its allied companies public and gaining them exposure to the investment community.
Notable employees
- Lindsay A. Rosenwald, MD, Chairman and CEO of Paramount Capital group of companies
- Joshua A. Kazam, MD, Managing Director
- J. Jay Lobell, MD, Registered Representative
- Michael Weiser, MD, PhD., Director of Research
- David Benshoof Klein, Managing Director & Head of Global Recruiting at Paramount BioCapital
- Timothy McInerney, former Managing Director of Paramount Biocapital, Inc.
- Wayne L. Rubin, CPA, former Chief Financial Officer
References
- Frederal Election Commission. Contributions by Employer
- SECURITIES OFFERINGS. DEALERS; BROKERS
- Paramount BioCapital, Inc. on BusinessWeek